George Stephen Leads Rapid-Response Drug Development Through High-Performing Global Teams at Gilead Sciences
DUBLIN, CA, UNITED STATES, March 31, 2026 /EINPresswire.com/ -- Through transformative approaches to drug development, Gilead Sciences is accelerating the delivery of innovative therapies, with George Stephen contributing to this vision in his role as …